The 1,3-dipolar cycloaddition reaction of (E)-7-arylidene-3-(1H-benzotriazol-1-yl)-6,7-dihydroindolizin-8(5H)-one and azomethine ylide which was generated in situ by the reaction of 11H-indeno[1,2-b]quinoxalin-11-one and L-proline afforded novel 1'-aryl-3”-(1H-benzotriazol-1-yl)-5',5”,6',6”,7',7a'-hexahydro-1'H,8”H-dispiro[indeno[1,2-b]quinoxaline-11,3'-pyrrolizine-2',7”-indolizin]-8”-one in moderate yields. The structures of all the products were characterized thoroughly by NMR, IR spectra, HRMS together with X-ray crystallographic analysis.
Similar content being viewed by others
References
(a) Gothelf, K. V.; Jørgensen, K. A. Chem. Rev. 1998, 98, 863. (b) Tang, S.; Zhang, X.; Sun, J.; Niu, D.; Chruma, J. J. Chem. Rev. 2018, 118, 10393. (c) Trost, B. M.; Brennan, M. K. Synthesis 2009, 3003.
(a) Williams, B. M.; Trauner, D. J. Org. Chem. 2018, 83, 3061. (b) Hauduc, C.; Bélanger, G. J. Org. Chem. 2017, 82, 4703. (c) Men, Y.; Dong, J.; Wang, S.; Xu, X. Org. Lett. 2017, 19, 6712. (d) Lu, X.; Tian, F.; Xu, X.; Wang, N.; Zhang, Q. J. Am. Chem. Soc. 2003, 125, 10459. (e) Maroto, E. E.; Izquierdo, M.; Reboredo, S.; Marco-Martínez, J.; Filippone, S.; Martín, N. Acc. Chem. Res. 2014, 47, 2660. (f) Cho, E.; Shin, S.; Yoon, Y. G. J. Phys. Chem. C 2008, 112, 11667.
(a) Saliyeva, L. M.; Slyvka, N. Y.; Mel'nyk, D. A.; Rusanov, E. B.; Vas'kevich, R. I.; Vovk, M. V. Chem. Heterocycl. Compd. 2018, 54, 130. [Khim. Geterotsikl. Soedin. 2018, 54, 130.] (b) Hu, X.; Huang, Y.; Fu, X.; Li, X. Chem. Heterocycl. Compd. 2019, 55, 644. [Khim. Geterotsikl. Soedin. 2019, 55, 644.] (c) Finke, A. O.; Mironov, M. E.; Skorova, A. B.; Shults, E. E. Chem. Heterocycl. Compd. 2018, 54, 411. [Khim. Geterotsikl. Soedin. 2018, 54, 411.] (d) Korotaev, V. Y.; Kutyashev, I. B.; Barkov, A. Y.; Sosnovskikh, V. Y. Chem. Heterocycl. Compd. 2017, 53, 1192. [Khim. Geterotsikl. Soedin. 2017, 53, 1192.] (e) Ren, D.; Kuang, G.; Li, X. Chem. Heterocycl. Compd. 2018, 54, 1117. [Khim. Geterotsikl. Soedin. 2018, 54, 1117.] (f) Ren, D.; Hu, X.; Li, X. Chem. Heterocycl. Compd. 2019, 55, 275. [Khim. Geterotsikl. Soedin. 2019, 55, 275.]
(a) Filatov, A. S.; Knyazev, N. A.; Ryazantsev, M. N.; Suslonov, V. V.; Larina, A. G.; Molchanov, A. P.; Kostikov, R. R.; Boitsov, V. M.; Stepakov, A. V. Org. Chem. Front. 2018, 5, 595. (b) Alizadeh, A.; Moafi, L. Heterocycl. Commun. 2017, 23, 375. (c) Barkov, A. Y.; Zimnitskiy, N. S.; Kutyashev, I. B.; Korotaev, V. Y.; Sosnovskikh, V. Y. Chem. Heterocycl. Compd. 2018, 54, 43. [Khim. Geterotsikl. Soedin. 2018, 54, 43.] (d) Barkov, A. Y.; Zimnitskiy, N. S.; Kutyashev, I. B.; Korotaev, V. Y.; Sosnovskikh, V. Y. Chem. Heterocycl. Compd. 2017, 53, 1315. [Khim. Geterotsikl. Soedin. 2017, 53, 1315.]
(a) Stępień, M.; Gońka, E.; Żyła, M.; Sprutta, N. Chem. Rev. 2017, 117, 3479. (b) Li, J.; Chen, S.; Wang, Z. Chem. Rec. 2016, 16, 1518.
(a) Tseng, C.-H.; Chen, Y.-R.; Tzeng, C.-C.; Liu, W.; Chou, C.-K.; Chiu, C.-C.; Chen, Y.-L. Eur. J. Med. Chem. 2016, 108, 258. (b) Selvam, P.; Clercq, E. D.; Pannecouque, C. Int. J. Drug Des. Discovery 2013, 4, 1017. (c) Schepetkin, I. A.; Kirpotina, L. N.; Khlebnikov, A. I.; Hanks, T. S.; Kochetkova, I.; Pascual, D. W.; Jutila, M. A.; Quinn, M. T. Mol. Pharmacol. 2012, 81, 832.
Reddy, M. V. R.; Rao, M. R.; Rhodes, D.; Hansen, M. S. T.; Rubins, K.; Bushman, F. D.; Venkateswarlu, Y.; Faulkner, D. J. J. Med. Chem. 1999, 42, 1901.
De, A. U.; Saha, B. P. J. Pharm. Sci. 1973, 62, 1897.
Wan, Y.; Dai, N.; Tang, Z.; Fang, H. Eur. J. Med. Chem. 2018, 146, 471.
La Pietra, V.; La Regina, G.; Coluccia, A.; Famiglini, V.; Pelliccia, S.; Plotkin, B.; Eldar-Finkelman, H.; Brancale, A.; Ballatore, C.; Crowe, A.; Brunden, K. R.; Marinelli, L.; Novellino, E.; Silvestri, R. J. Med. Chem. 2013, 56, 10066.
James, D. A.; Koya, K.; Li, H.; Chen, S.; Xia, Z.; Ying, W.; Wu, Y.; Sun, L. Bioorg. Med. Chem. Lett. 2006, 16, 5164.
(a) Fu, X.; Meng, Y.; Li, X.; Stepien, M.; Chmielewski, P. J. Chem. Commun. 2018, 54, 2510. (b) Li, X.; Liu, B.; Yu, X.; Yi, P.; Yi, R.; Chmielewski, P. J. J. Org. Chem. 2012, 77, 2431. (c) Yang, L.-L.; Li, X.-F.; Hu, X.-L.; Yu, X.-Y. Tetrahedron Lett. 2016, 57, 1265. (d) Ren, D.; Liu, B.; Li, X.; Koniarz, S.; Pawlicki, M.; Chmielewski, P. J. Org. Chem. Front. 2019, 6, 908. (e) Liu, B.; Li, X.-F.; Liu, H.-C.; Yu, X.-Y. Tetrahedron Lett. 2013, 54, 6952. (f) Ren, D.; Koniarz, S.; Li, X.; Chmielewski, P. J. Chem. Commun. 2020, 56, 4836. (g) Huang, Y.; Tang, G.; Ren, D.; Zeng, J.-L.; Li, X. Chem. Heterocycl. Compd. 2020, 56, 42. [Khim. Geterotsikl. Soedin. 2020, 56, 42.] (h) Huang, Y.; Ren, D.; Yu, X.; Zeng, J.-L.; Li, X. Chem. Heterocycl. Compd. 2020, 56, 84. [Khim. Geterotsikl. Soedin. 2020, 56, 84.]
(a) Raj, A. A.; Raghunathan, R.; SrideviKumari, M. R.; Raman, N. Bioorg. Med. Chem. 2003, 11, 407. (b) Periyasami, G.; Raghunathan, R.; Surendiran, G.; Mathivanan, N. Bioorg. Med. Chem. Lett. 2008, 18, 2342. (c) Kumar, R. R.; Perumal, S.; Manju, S. C.; Bhatt, P.; Yogeeswari, P.; Sriram, D. Bioorg. Med. Chem. Lett. 2009, 19, 3461. (d) Babu, A. R. S.; Raghunathan, R. Tetrahedron Lett. 2008, 49, 4487. (e) Babu, A. R. S.; Raghunathan, R. Tetrahedron Lett. 2007, 48, 6809.
Barkov, A. Y.; Zimnitskiy, N. S.; Korotaev, V. Y.; Kutyashev, I. B.; Moshkin, V. S.; Sosnovskikh, V. Y. Chem. Heterocycl. Compd. 2017, 53, 451. [Khim. Geterotsikl. Soedin. 2017, 53, 451.]
Kumar, R. R.; Perumal, S.; Senthilkumar, P.; Yogeeswari, P.; Sriram, D. Tetrahedron 2008, 64, 2962.
Huang, Y.; Lei, J.; Fu, X.; Xie, W.; Li, X. J. Chem. Res. 2019, 43, 179.
(a) APEX2; Bruker-AXS: Madison, 2014. (b) SAINT; Bruker-AXS: Madison, 2014. b Sheldrick, G. M. SADABS; University of Göttingen: Göttingen, 1996. c Dolomanov, O. V.; Bourhis, L. J.; Gildea, R. J.; Howard, J. A. K.; Puschmann, H. J. Appl. Crystallogr. 2009, 42, 339. d Sheldrick, G. M. Acta Crystallogr., Sect. C: Struct. Chem. 2015, C71, 3.
Author information
Authors and Affiliations
Corresponding author
Additional information
Published in Khimiya Geterotsiklicheskikh Soedinenii, 2021, 57(2), 181–186
Rights and permissions
About this article
Cite this article
Ling, Y., Huang, Y. & Li, X. Synthesis of 1'-aryl-3''-(1H-benzotriazol-1-yl)-5',5'',6',6'',7',7a'-hexahydro-1'H,8''H-dispiro[indeno[1,2-b]quinoxaline-11,3'-pyrrolizine-2',7''-indolizin]-8''-ones via cycloaddition reaction. Chem Heterocycl Comp 57, 181–186 (2021). https://doi.org/10.1007/s10593-021-02891-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10593-021-02891-w